WO2007138462A3 - Aqueous oral formulations of risperidone - Google Patents
Aqueous oral formulations of risperidone Download PDFInfo
- Publication number
- WO2007138462A3 WO2007138462A3 PCT/IB2007/001424 IB2007001424W WO2007138462A3 WO 2007138462 A3 WO2007138462 A3 WO 2007138462A3 IB 2007001424 W IB2007001424 W IB 2007001424W WO 2007138462 A3 WO2007138462 A3 WO 2007138462A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- risperidone
- oral formulations
- aqueous oral
- relates
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to stable aqueous solution of risperidone or salts thereof for oral administration. The invention also relates to processes for preparation of such formulations.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN834/MUM/2006 | 2006-06-01 | ||
IN834MU2006 | 2006-06-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007138462A2 WO2007138462A2 (en) | 2007-12-06 |
WO2007138462A3 true WO2007138462A3 (en) | 2009-04-23 |
Family
ID=38779048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/001424 WO2007138462A2 (en) | 2006-06-01 | 2007-05-31 | Aqueous oral formulations of risperidone |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007138462A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2457824C2 (en) * | 2010-07-06 | 2012-08-10 | Алексей Шамильевич Сюников | Therapeutic and prophylactic toothpaste "stomatol" |
GB2569940B (en) * | 2017-11-01 | 2022-10-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453425A (en) * | 1994-07-11 | 1995-09-26 | Janssen Pharmaceutica N.V. | Risperidone oral formulation |
-
2007
- 2007-05-31 WO PCT/IB2007/001424 patent/WO2007138462A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453425A (en) * | 1994-07-11 | 1995-09-26 | Janssen Pharmaceutica N.V. | Risperidone oral formulation |
US5616587A (en) * | 1994-07-11 | 1997-04-01 | Janssen Pharmaceutica N.V. | Aqueous risperidone formulations |
USRE39181E1 (en) * | 1994-07-11 | 2006-07-11 | Francois Marc Karel Jozef | Aqueous risperidone formulations |
Non-Patent Citations (3)
Title |
---|
JANSSEN ET AL.: "Pharmacology of Risperidone (R 64 766), a New Antipsychotic with Serotonin-S2 and Dopamine-D2 Antagonistic Properties", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS., vol. 244, no. 2, 1988, pages 685 - 693 * |
LEYSEN ET AL.: "Biochemical Profile of Risperidone, a New Antipsychotic", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS., vol. 247, no. 2., 1988, pages 661 - 670 * |
LOFTSSON ET AL.: "Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization", JOURNAL OF PHARMACEUTICAL SCIENCES., vol. 85, no. 10, October 1996 (1996-10-01), pages 1017 - 1025 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007138462A2 (en) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012021715A3 (en) | Stable formulations of linaclotide | |
EP2340821A4 (en) | Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient | |
WO2011012816A3 (en) | Pharmaceutical formulation | |
IL193074A0 (en) | Stable pharmaceutical formulations of montelukast sodium | |
WO2011017502A3 (en) | Linaclotide-containing formulations for oral administration | |
WO2009115178A3 (en) | Gingival wafer | |
WO2010092090A3 (en) | Novel salts of sitagliptin | |
WO2009032034A3 (en) | Stabilized picoplatin dosage form | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
PT2076244T (en) | Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof | |
WO2008035359A3 (en) | Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives | |
WO2009016498A8 (en) | Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions | |
WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
WO2007070517A3 (en) | Fexofenadine suspension formulation | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2011006935A3 (en) | Tetrazole derivatives | |
WO2009013545A3 (en) | Chemical compounds | |
WO2011141488A3 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
WO2012037562A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
ZA201107412B (en) | Methods for the preparation of [2-8,9-dioxo2,6-diazabicyclo[5.2.0]non-1(1)-en-2-yl)ethyl]phosphonic acid and precursors thereof | |
WO2006129160A3 (en) | Stable aqueous oral solution of risperidone | |
WO2008081268A3 (en) | Pharmaceutical compositions of entacapone | |
WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium | |
EP2196463A4 (en) | Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07734715 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07734715 Country of ref document: EP Kind code of ref document: A2 |